000046266 000__ 01151cam\a22003975i\4500
000046266 001__ 46266
000046266 003__ SzGeWIPO
000046266 005__ 20230511163320.0
000046266 006__ m\\\\eo\\d\\\\\\\\
000046266 007__ cr bn |||m|||a
000046266 008__ 220608s2020\\\\nyu\\\\\o\\\\\000\0\eng\d
000046266 035__ $$a(OCoLC)1335039459
000046266 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000046266 041__ $$aeng
000046266 24500 $$aUh-oh we are in trouble! Compulsory licences v data exclusivity in the EU: one more challenge to overcome in the race to find a COVID-19 vaccine?.
000046266 264_1 $$a[New York, NY] :$$bThomson Reuters,$$c2020
000046266 300__ $$a1 online resource
000046266 336__ $$atext$$2rdacontent
000046266 337__ $$acomputer$$2rdamedia
000046266 338__ $$aonline resource$$bcr$$2rdacarrier
000046266 4901_ $$aEuropean Intellectual Property Review,$$x0142-0461 ;$$vVolume 42, Issue 9
000046266 542__ $$fhttps://1.next.westlaw.com/Copyright
000046266 588__ $$aCrossref
000046266 590__ $$aPublished online: 2020
000046266 650_0 $$aIntellectual property.
000046266 650_4 $$aCOVID-19 pandemic
000046266 650_0 $$aVaccines.
000046266 650_0 $$aPublic health$$zEurope.
000046266 7001_ $$aChandler, Dhanay Cadillo,$$eauthor.
000046266 7731_ $$tEuropean Intellectual Property Review
000046266 7731_ $$wEIPR
000046266 830_0 $$aEuropean Intellectual Property Review,$$vE.I.P.R. 2020, 42(9), 539-547
000046266 85641 $$uhttps://www.westlaw.com/Document/I7C4C629013F811EB8A6DF81E2F4F9E86/View/FullText.html?transitionType=Default&contextData=(sc.Default)&VR=3.0&RS=cblt1.0&sp=wlnintell-000$$yonline version
000046266 904__ $$aArticle
000046266 980__ $$aEIPR